Breast Conserving Therapy Shows Survival Benefit Compared to Mastectomy in Early-Stage Patients with Hormone Receptor Positive Disease
University of Texas MD Anderson Cancer CenterWhen factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone-receptor positive disease, according to research from The University of Texas MD Anderson Cancer Center.